Log in to your Inderes Free account to see all free content on this page.
Swedish Orphan Biovitrum
427.80 SEK
+1.86 %
Less than 1K followers
SOBI
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Swedish Orphan Biovitrum
P/E
Median 2019-2025
EV/S
Median 2019-2024
EV/EBIT
Median 2019-2024
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 147.57 | 158.65 | 176.80 | 206.03 | 267.00 | 317.40 | 332.80 |
| Shares | 306.4 | 308.1 | 308.1 | 309.9 | 339.8 | 343.4 | 357.4 |
| Market cap | 45,214.3 | 48,883.1 | 54,474.7 | 63,850.4 | 90,715.1 | 109,008.8 | 118,947.0 |
| Enterprise value | 60,618.3 | 63,050.1 | 63,974.7 | 71,590.4 | 110,296.1 | 124,603.8 | - |
| EV/S | 4.3 | 4.1 | 4.1 | 3.8 | 5.0 | 4.8 | - |
| EV/EBITDA | 10.2 | 9.2 | 11.1 | 11.5 | 15.2 | 13.4 | - |
| EV/EBIT | 13.4 | 13.1 | 17.1 | 18.8 | 27.1 | 22.2 | - |
| P/E | 13.7 | 15.1 | 20.3 | 24.2 | 35.7 | 27.9 | 239.4 |
| P/B | 2.67 | 2.42 | 2.35 | 2.41 | 2.68 | 2.71 | 3.15 |
| P/S | 3.2 | 3.2 | 3.5 | 3.4 | 4.1 | 4.2 | 4.2 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 37.1 % | 41.8 % | 47.7 % | 50.5 % | 45.7 % | 53.4 % | 55.9 % |
| Gearing ratio | 97.3 % | 72.1 % | 47.0 % | 34.3 % | 60.5 % | 41.5 % | 30.5 % |
Login required
This content is only available for logged in users